dapagliflozin propanediol
The propanediol form of dapagliflozin, a selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity. Upon administration, dapagliflozin selectively targets and inhibits SGLT2, thereby preventing the reabsorption of glucose by the kidneys.
| Synonym: | dapagliflozin propylene glycol hydrate dapagliflozin S-propylene glycol monohydrate |
|---|---|
| US brand name: | Farxiga |
| Chemical structure: | D-glucitol, 1,5-anhydro-1-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-, (1S)-, compd. with (2S)-1,2-propanediol, hydrate (1:1:1) |